Deutsche Bank
SGMT icon

Deutsche Bank’s Sagimet Biosciences SGMT Stock Holding History

Deutsche Bank’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Buy
+58,202
New +$396K ﹤0.01% 2830
2024
Q2 		– Sell
-9,720
Closed -$52.7K – 3685
2024
Q1 		$52.7K Buy
+9,720
New +$69.8K ﹤0.01% 3384

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Deutsche Bank's SGMT Position: Q2 2026 in Review

Deutsche Bank opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 58,202 shares worth $450K. The stake represents ﹤0.01% of the portfolio and ranks #2830 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in SGMT as recently as Q1 2024.

Deutsche Bank first reported a position in SGMT in Q1 2024 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Deutsche Bank held 58,202 shares of Sagimet Biosciences worth $450K as of Q2 2026.
  • Sagimet Biosciences was a new Deutsche Bank position in Q2 2026.
  • Sagimet Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2830 holding.
  • Deutsche Bank first reported a position in Sagimet Biosciences in Q1 2024 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.